Carmell
Carmell Announces Closing of Elevai Skincare Acquisition
16 janv. 2025 08h00 HE | Carmell Corporation
Carmell Announces Closing of Elevai Skincare Acquisition
Qsight-Guidepoint-Vert-(RGB).jpg
GLP-1 Medications Fuel Growth in Medical Aesthetics, with Weight Loss Accounting for 11% of Non-Surgical Spending in 2024
09 janv. 2025 09h00 HE | Guidepoint Qsight
GLP-1 medications drove 13% of non-surgical aesthetic spend in 2024, reshaping the $19.2B industry as medspas see rising revenue and younger patients.
Logo for Cytrellis Biosystems
Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financing
07 janv. 2025 08h15 HE | Cytrellis Bioscience
Cytrellis marks new era of growth with the launch of ellacor 2.0, fueled by the completion of new financing and theappointment of Dr. Denise Dajles as CEO.
Carmell
Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
03 janv. 2025 08h00 HE | Carmell Corporation
PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
Carmell
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
02 janv. 2025 08h00 HE | Carmell Corporation
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
Carmell
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
24 déc. 2024 08h30 HE | Carmell Corporation
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
Olansky-Logo-Stacked-Final.png
Trent Renta Promoted to Chief Operating Officer at Olansky Dermatology & Aesthetics in Atlanta, Georgia
18 nov. 2024 16h44 HE | Olansky Dermatology & Aesthetics
Trent Renta promoted to Chief Operating Officer at Olansky Dermatology & Aesthetics in Atlanta, Georgia.
Olansky-Logo-Stacked-Final.png
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky retires after more than 40 years of clinical practice
10 oct. 2024 12h24 HE | Olansky Dermatology & Aesthetics
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky retires after more than 40 years of clinical practice.
LeaderMed Group and Combiphar Form Joint Venture on LM-008, a Novel GLP-1 Dual Agonist, Targeting Indonesia's High Diabetes and/or Obesity Prevalence
30 sept. 2024 22h00 HE | LeaderMed Group; Combiphar
LeaderMed and Combiphar form a joint venture to tackle Indonesia’s diabetes and obesity crisis with LM-008 and UltraSculpt, launching a Phase 3 trial.
ASDS Experts Share P
ASDS Experts Share Procedural Dermatology Techniques at Unique Hands-on Course With Innovative 3D Technology
16 sept. 2024 07h00 HE | American Society for Dermatologic Surgery
Schaumburg, IL, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery (ASDS) welcomed more than 50 dermatologic surgeons and dermatology residents to its new course, “ASDS...